Nomura Asset Management Co. Ltd. Has $4.47 Million Stock Holdings in Align Technology, Inc. $ALGN

Nomura Asset Management Co. Ltd. grew its stake in Align Technology, Inc. (NASDAQ:ALGN) by 10.1% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 23,618 shares of the medical equipment provider’s stock after acquiring an additional 2,160 shares during the period. Nomura Asset Management Co. Ltd.’s holdings in Align Technology were worth $4,472,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. True Wealth Design LLC increased its position in shares of Align Technology by 7,650.0% during the 2nd quarter. True Wealth Design LLC now owns 155 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 153 shares during the last quarter. Cromwell Holdings LLC increased its holdings in Align Technology by 2,900.0% during the second quarter. Cromwell Holdings LLC now owns 180 shares of the medical equipment provider’s stock worth $34,000 after buying an additional 174 shares during the last quarter. SVB Wealth LLC bought a new stake in Align Technology during the first quarter worth $36,000. Farther Finance Advisors LLC raised its holdings in shares of Align Technology by 42.2% in the 2nd quarter. Farther Finance Advisors LLC now owns 310 shares of the medical equipment provider’s stock valued at $59,000 after purchasing an additional 92 shares during the period. Finally, Covestor Ltd raised its stake in Align Technology by 18.8% in the first quarter. Covestor Ltd now owns 493 shares of the medical equipment provider’s stock valued at $78,000 after buying an additional 78 shares during the period. Institutional investors own 88.43% of the company’s stock.

Align Technology Stock Up 7.3%

Shares of ALGN opened at $142.56 on Friday. The business’s fifty day moving average is $132.93 and its 200 day moving average is $157.80. Align Technology, Inc. has a 12-month low of $122.00 and a 12-month high of $246.19. The stock has a market cap of $10.23 billion, a P/E ratio of 27.63, a P/E/G ratio of 1.49 and a beta of 1.84.

Align Technology (NASDAQ:ALGN) last released its quarterly earnings data on Wednesday, October 29th. The medical equipment provider reported $2.61 earnings per share for the quarter, topping the consensus estimate of $2.38 by $0.23. The firm had revenue of $995.69 million for the quarter, compared to the consensus estimate of $980.75 million. Align Technology had a net margin of 9.50% and a return on equity of 14.06%. The business’s revenue was up 1.8% on a year-over-year basis. During the same quarter in the prior year, the company posted $2.35 earnings per share. Align Technology has set its Q4 2025 guidance at EPS. On average, analysts expect that Align Technology, Inc. will post 7.98 EPS for the current year.

Align Technology announced that its Board of Directors has initiated a stock buyback program on Tuesday, August 5th that authorizes the company to buyback $200.00 million in shares. This buyback authorization authorizes the medical equipment provider to reacquire up to 2% of its stock through open market purchases. Stock buyback programs are usually a sign that the company’s management believes its stock is undervalued.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on ALGN shares. Zacks Research upgraded shares of Align Technology from a “strong sell” rating to a “hold” rating in a research note on Tuesday, September 30th. Mizuho dropped their price target on Align Technology from $210.00 to $170.00 and set an “outperform” rating for the company in a research note on Monday, October 13th. HSBC upped their target price on Align Technology from $140.00 to $150.00 in a research note on Friday, October 31st. Morgan Stanley raised their price target on shares of Align Technology from $142.00 to $154.00 and gave the company an “equal weight” rating in a research note on Thursday, October 30th. Finally, Leerink Partners boosted their price objective on Align Technology from $172.00 to $189.00 in a research report on Thursday, October 30th. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, seven have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat, Align Technology currently has a consensus rating of “Hold” and a consensus price target of $175.45.

Align Technology Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.